Bioventus (BVS) Receivables - Net (2020 - 2026)

Bioventus (BVS) has 7 years of Receivables - Net data on file, last reported at $120.5 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 2.07% year-over-year to $120.5 million; the trailing twelve-month figure through Mar 2026 stood at $120.5 million (up 2.07% YoY), and the FY2025 full-year result was $131.2 million, up 0.73% from the prior year.
• Receivables - Net for Q1 2026 stood at $120.5 million, down from $131.2 million in the prior quarter.
• Across five years, Receivables - Net topped out at $148.3 million in Q3 2022 and bottomed at $112.9 million in Q3 2023.
• The 5-year median for Receivables - Net is $128.7 million (2024), against an average of $129.0 million.
• The widest annual swing landed in 2022, when Receivables - Net jumped 41.18%; it then decreased 14.59% in 2023.
• A 5-year view of Receivables - Net shows it stood at $136.3 million in 2022, then declined by 6.81% to $127.0 million in 2023, then increased by 2.56% to $130.3 million in 2024, then gained by 0.73% to $131.2 million in 2025, then dropped by 8.14% to $120.5 million in 2026.
• The last three Receivables - Net figures came in at $120.5 million (Q1 2026), $131.2 million (Q4 2025), and $130.4 million (Q3 2025), per Business Quant data.

Peer Comparison